Pamela Anne Maher

Virogenics, Inc.

NIH Rank #1188
  • Program Leader
  • R01 Holder
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$4.8M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#1,188
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $4.8M across 3 grants · National rank #1188.

Top grants by award amount

Pamela Anne Maher's NIH grant portfolio, ranked by award amount.

  • 1R44AG085775-01A1R44
    Paving the Way to Phase 2 Trials of CMS121 for Alzheimer's Disease
    $2.4M
    award amount
  • 1U01AG084549-01U01
    Long-term, non-clinical toxicology for advancing CMS121 to Phase 2 trials for AD
    $1.6M
    award amount
  • 5R01AG069206-05R01
    Using geroscience to understand and treat Alzheimer's disease
    $769.1K
    award amount

Affiliations

Institutions that have administered grants for Pamela Anne Maher.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Virogenics, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1188
  6. 2024
    Entered Top 25% Nationally
    Ranked #1188
  7. 2024
    Entered Top 10% Nationally
    Ranked #1188
  8. 2024
    Multi-Institutional Research
    Awards at 2 institutions

Related investigators

Other NIH-funded PIs frequently associated with Pamela Anne Maher.